Ikonisys S.A. (EPA:ALIKO)
France · Delayed Price · Currency is EUR 1.520
0.00 (0.00%)
Jun 30, 2025, 5:15 PM CET
Ikonisys Revenue
In the year 2024, Ikonisys had annual revenue of 1.08M EUR with 139.68% growth. Ikonisys had revenue of 297.54K in the half year ending June 30, 2024, with 43.59% growth.
Revenue
1.08M
Revenue Growth
+66.64%
P/S Ratio
19.83
Revenue / Employee
107.51K
Employees
10
Market Cap
21.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08M | 626.53K | 139.68% |
| Dec 31, 2023 | 448.56K | -168.31K | -27.28% |
| Dec 31, 2022 | 616.87K | 74.17K | 13.67% |
| Dec 31, 2021 | 542.70K | 57.53K | 11.86% |
| Dec 31, 2020 | 485.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |